The Truth About Softgels: Phthalate-Free, Powered by Glycerin and Sorbitol
By Stephen Tindal
January 9, 2026
Catalent offers clarification after recent discussions raised concerns around softgels, phthalates and potential health risks
3 min read
False
Advertisement
Latest
A Turning Point in MASH
By HH Kim
January 8, 2026
A billion-dollar acquisition, breakthrough clinical data, and a shifting scientific paradigm are pushing MASH out of the shadows and into a new era of metabolic medicine.
3 min read
Inside 2026: The Industry’s AI Turning Point
January 7, 2026
The life sciences sector is bracing for a year when AI delivers real returns, regulators move faster, and trial operations are finally built for modern science.
6 min read
Building the Future of RNA Manufacturing
By Stefan Lutz
January 6, 2026
Can enzyme-catalyzed processes address the limitations of traditional RNA synthesis and define the future of scalable, sustainable manufacturing of RNA therapeutics?
5 min read
Learnings from a Scope 1 and 2 Climate-Neutral Manufacturing Facility
By Sebastián Arana
December 30, 2025
Merck’s climate-neutral facility shows how sustainability, supply-chain transparency, and cultural change can scale low-carbon biomanufacturing and build long-term resilience.
2 min read
Addressing the Regulatory Documentation Bottleneck to Transform Drug Approvals
By Anita Modi
December 29, 2025
Agentic AI combined with human control points creates a new paradigm for accelerating documentation while maintaining regulatory integrity.
5 min read
The Post-Pandemic Evolution of Antiviral Research
December 22, 2025
The pandemic catalyzed a transformation in antiviral R&D. From better data to open collaboration, Tetiana Matviyuk of Enamine describes how the landscape has evolved.
3 min read
New Approach Methodologies: Why the Future of Drug Development Must Be Human
By Hayley Gooding
December 18, 2025
NAMs aren’t just a scientific upgrade, but a moral and practical necessity. The tools are ready. The question is: does the industry have the will to use them?
3 min read
Promising Data For Off-the-Shelf Gene-edited Cell Therapy
December 17, 2025
New clinical results outline patient responses to a donor-derived, gene-edited cell therapy in relapsed and refractory T-cell leukemia
2 min read
Bridging the Digital Divide: How Collaboration and Standardization Are Shaping the Future of Biotech
By Heather Purvis
December 17, 2025
The promise of cell and gene therapy is boundless, but data silos are holding it back. Standardization, interoperability, and collaboration can move data as freely as science itself.
5 min read
